Kezar Life Sciences, Inc. — Director's Dealing 2019

Jun 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2019-06-25

Reporting Person: BERGER FRANKLIN M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-25	Stock Option (Right to Buy)	$7.63	A	8896	Acquired	2029-06-24	Common Stock (8896)	Direct

Footnotes

F1: One-hundred percent (100%) of the shares subject to the option shall vest on 6/25/2020, subject to Reporting Person continuing to provide service through such date.